Generali's earnings per share without non-recurring items for the
three
months ended in Dec. 2025 was €0.68.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was €3.04.
During the past 12 months, Generali's average earnings per share (NRI) Growth Rate was 9.50% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 20.60% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 13.80% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 6.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Generali's EPS without NRI or its related term are showing as below:
FRA:ASG'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -39.9 Med: 5.65 Max: 55
Current: 20.6
During the past 13 years, Generali's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 55.00% per year. The lowest was -39.90% per year. And the median was 5.65% per year.
FRA:ASG's 3-Year EPS without NRI Growth Rate is ranked better than 56.58% of 403
companies
in the Insurance industry
Industry Median: 16.4
vs FRA:ASG: 20.60
Generali's EPS (Diluted) for the
three
months ended in Dec. 2025 was €0.58.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €2.83.
Generali's EPS (Basic) for the
three
months ended in Dec. 2025 was €0.63.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was €2.88.
Generali (FRA:ASG) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Generali EPS without NRI Related Terms
Generali EPS without NRI Historical Data
* Premium members only.
The historical data trend for Generali's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:ASG vs BRK.A, AIG, HIG: EPS without NRI Comparison
For the Insurance - Diversified subindustry, Generali's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Generali PE Ratio without NRI vs Insurance Industry
For the Insurance industry and Financial Services sector, Generali's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Generali's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Generali (FRA:ASG) has a EPS without NRI of €3.04 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Generali and its competitors. According to the industry distribution chart, Generali ranks #175 out of 403 companies in the Insurance industry, placing it in the top 43.4%.
Is Generali's EPS without NRI too high?
Generali's current EPS without NRI is €3.04. Based on the distribution chart, Generali ranks #175 out of 403 companies in the Insurance industry, which is above the industry midpoint. Overall, Generali has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Generali's EPS without NRI compare to BRK.A and AIG?
According to the Insurance industry distribution chart, Generali ranks #175 out of 403 companies for EPS without NRI. This puts Generali in the upper half of its industry. The industry median EPS without NRI is 16.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for an Insurance company?
The median EPS without NRI among Insurance companies is 16.40, based on 403 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Generali and its competitors. For the Insurance industry, the median EPS without NRI is 16.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Generali's current EPS without NRI is €3.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Generali stock overvalued right now?
Based on GuruFocus' analysis, Generali (FRA:ASG) is currently considered Modestly Overvalued. The stock's GF Value™ is €38.57, compared to a current price of €42.70 — trading 10.7% above its estimated fair value. The current EPS without NRI is €3.04. Generali's overall GF Score™ is 56/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Generali (FRA:ASG), the current EPS without NRI is €3.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Generali (FRA:ASG) Overvalued in 2026?
Based on GuruFocus' analysis, Generali stock appears to be overvalued.
The current stock price of €42.70 is trading 10.7% above its estimated GF Value™ of €38.57.
GuruFocus considers Generali to be Modestly Overvalued.
Key valuation signals for FRA:ASG:
EPS without NRI: €3.04
GF Value™: €38.57 vs. price of €42.70 (10.7% above fair value)
No single metric tells the full story. See the FRA:ASG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The roots of Generali date back to the 1830s and the Bora wind and rough seas that hit the Trieste region. Over that decade, Generali sought to expand throughout Italy, but growth was held back by the fragmented nature of Italy. The Italian Revolution in the 1840s paved the way for easier expansion in the country. After World War I, Trieste was handed back to Italy. The dissolution of the Austro-Hungarian Empire created a fragmented Europe and a fragmented Generali. To this day, Generali remains quite a diversified company, with its core operations remaining in the historical Austro-Hungarian countries of Austria, Central and Eastern Europe, Germany, and Italy. France is also an important contributor to life and savings.
56GF Score
Get the complete analysis for FRA:ASG
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ASG has been successfully added to your 
